Next |
home / stock / agle / agle message board
Subject | By | Source | When |
---|---|---|---|
$AGLE she is green | subslover | investorshub | 06/23/2023 4:17:08 PM |
AGLE: Interesting points there, Colonel Subs! | Invest-in-America | investorshub | 06/23/2023 1:01:53 PM |
oh my | The Night Stalker | investorshub | 06/23/2023 4:02:02 AM |
Now is not the time for most OTC | subslover | investorshub | 06/22/2023 9:55:58 PM |
Bought .39-.45 sold .75-70, $$$$$ | harry crumb | investorshub | 06/22/2023 9:29:35 PM |
Yep it will | harry crumb | investorshub | 06/22/2023 9:28:14 PM |
Heck, @HALB used to have a PR at | Invest-in-America | investorshub | 06/22/2023 9:13:34 PM |
This pump and dump scam will come back | Volcano | investorshub | 06/22/2023 7:03:23 PM |
LOL. I had made good money with $HALB | subslover | investorshub | 06/22/2023 6:44:29 PM |
AGLE: Go-go-go!! | Invest-in-America | investorshub | 06/22/2023 6:18:39 PM |
I know that's just a sarcastic joke. | subslover | investorshub | 06/22/2023 6:11:53 PM |
A much, much, much, WISER choice on your | Invest-in-America | investorshub | 06/22/2023 5:52:42 PM |
Already found that in my savior JC | Triple nickle | investorshub | 06/22/2023 5:34:55 PM |
Tomorrow, Boss!!! When $HALB PR's that the US | Invest-in-America | investorshub | 06/22/2023 5:26:55 PM |
Shorts are screwed | Triple nickle | investorshub | 06/22/2023 5:22:04 PM |
Hmmmm they need shares Showing drop it thirty | Triple nickle | investorshub | 06/22/2023 5:21:09 PM |
Added some right here | Triple nickle | investorshub | 06/22/2023 5:19:22 PM |
The good ole days of the OTC will | subslover | investorshub | 06/22/2023 5:05:23 PM |
Anytime. I consider this a speculative long term hold | subslover | investorshub | 06/22/2023 5:04:29 PM |
AGLE: And you are WELCOME, Boss!! And indeed, | Invest-in-America | investorshub | 06/22/2023 5:01:20 PM |
News, Short Squeeze, Breakout and More Instantly...
Aeglea BioTherapeutics Inc. Company Name:
AGLE Stock Symbol:
NASDAQ Market:
Aeglea BioTherapeutics Inc. Website:
Aeglea BioTherapeutics Announces Name Change to Spyre Therapeutics, Appoints CEO and Additional Directors, and Expands Leadership Team to Develop Next-Generation Therapeutic Combinations for the Treatment of IBD PR Newswire Company will begin trading on Nasdaq under trading sy...
2023-11-20 05:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Aeglea BioTherapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update PR Newswire Continued progress across the Company's potentially best-in-class inflammatory bowel disease (IBD) portfolio SPY001, a half-life extended anti-α4β...